Status: current, Defined. Date: 31-Mar 2015. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2760811000168116 | Hepasol (bovine liver 38.67 mg / 10 mL + calcium 16.72 mg / 10 mL + iron 3.3 mg / 10 mL + manganese 488 microgram / 10 mL + potassium 2.74 mg / 10 mL + sodium 1.59 mg / 10 mL + thiamine hydrochloride 1.19 mg / 10 mL) oral liquid, 200 mL (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2760821000168111 | Hepasol oral liquid, 200 mL | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Hepasol oral liquid, 200 mL | Is a | trade product pack | true | Inferred relationship | Some | ||
| Hepasol oral liquid, 200 mL | Is a | iron 3.3 mg/10 mL + calcium 16.72 mg/10 mL + potassium 2.74 mg (potassium 0.07 mmol)/10 mL + sodium 1.59 mg/10 mL + manganese 488 microgram/10 mL + thiamine hydrochloride 1.19 mg/10 mL + bovine liver 38.67 mg/10 mL oral liquid, 200 mL | true | Inferred relationship | Some | ||
| Hepasol oral liquid, 200 mL | has TPUU | Hepasol oral liquid, 10 mL | true | Inferred relationship | Some | 1 | |
| Hepasol oral liquid, 200 mL | has TP | Hepasol | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Hepasol oral liquid, 200 mL, bottle | Is a | True | Hepasol oral liquid, 200 mL | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR